Center-Authored Papers
Filters: Author is Hortobagyi, Gabriel N [Clear All Filters]
SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(1):58-64. Abstract
.
2015.
A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338.. Clinical breast cancer. 8(6):511-5. Abstract
.
2008.
A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102.. Breast cancer research and treatment. 143(2):351-8. Abstract
.
2014.
Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(5):814-9. Abstract
.
2008.
Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.. The American journal of pathology. 176(4):1639-47. Abstract
.
2010.
Promoting Quality and Evidence-Based Care in Early-Stage Breast Cancer Follow-up.. Journal of the National Cancer Institute. Abstract
.
2014.
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(20):2627-33. Abstract
.
2013.
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226.. British journal of clinical pharmacology. Abstract
.
2016.
EGFR signaling enhances aerobic glycolysis in triple negative breast cancer cells to promote tumor growth and immune escape.. Cancer research. 76(5):1284-1296. Abstract
.
2016.
Combination anastrozole and fulvestrant in metastatic breast cancer.. The New England journal of medicine. 367(5):435-44. Abstract
.
2012.
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.. The New England journal of medicine. 372(10):923-32. Abstract
.
2015.
Phase II studies of two different schedules of dasatinib in ***bone metastasis predominant metastatic breast cancer: SWOG S0622.. Breast cancer research and treatment. Abstract
.
2016.
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
.
2014.
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.. Mayo Clinic proceedings.
.
2015.
Supplement use during an intergroup clinical trial for breast cancer (S0221).. Breast cancer research and treatment. 137(3):903-13. Abstract
.
2013. Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)